American Healthcare REIT, Inc. AHR

Q2 FY2026 · ended Jun 30, 2026 · Revenue $634.52M, +26.6% YoY · Filed Aug 7, 2026

American Healthcare REIT, Inc. (AHR) files with the SEC under industry code 6798, Real Estate Investment Trusts. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $634.5 million and net income of $30.6 million. As of Jun 30, 2026 it held $156.9 million in cash and investments and $144.2 million in total debt.

Revenue
$634.52M
+26.6% vs year-ago quarter
Net income
$30.61M
+208.9% vs year-ago quarter
Operating cash flow
$118.62M
+66.0% vs year-ago quarter
Free cash flow
—
EPS
$0.16
+166.7% vs year-ago quarter
Dividend per share
$0.25
+0.0% vs year-ago quarter
Shares outstanding
218.00M
+29.3% vs year-ago quarter
Net cash
$12.71M
Q2 FY2026
Operating margin
20.5%
TTM

Company profile

Industry
Real Estate Investment Trusts (SIC 6798)
Listed as
AHR (NYSE)
Fiscal year ends
December 31
Incorporated in
MD
Headquarters
Irvine, CA
SEC filer status
Large accelerated filer
SEC CIK
1632970
Former names
Griffin-American Healthcare REIT IV, Inc. (until Sep 30, 2021); Griffin-American Healthcare REIT 4, Inc. (until Oct 23, 2015)

Other Real Estate Investment Trusts companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Revenue
$634.5M
$609.8M
$564.0M
$532.1M
$501.3M
Operating income
$137.2M
$125.5M
$111.6M
$105.8M
$103.2M
Net income
$30.6M
$23.7M
$10.8M
$55.9M
$9.9M
Diluted EPS
$0.16
$0.13
$0.06
$0.33
$0.06
Operating cash flow
$118.6M
$81.1M
$55.2M
$107.2M
$71.5M
Total assets
$5.7B
$5.6B
$5.4B
$4.8B
$4.5B
Total liabilities
$2.0B
$2.1B
$2.1B
$2.1B
$2.0B
Stockholders' equity
$3.7B
$3.5B
$3.3B
$2.7B
$2.4B
Cash and investments
$156.9M
$119.4M
$114.8M
$147.4M
$133.5M
Total debt
$144.2M
$164.5M
$169.5M
$175.4M
$182.6M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2026 Nov 5, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 18, 2026 Sep 18, 2026
8-K Current report
Regulation FD disclosure
Sep 14, 2026 Sep 14, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 2, 2026 Sep 2, 2026
8-K Current report
Regulation FD disclosure
Sep 1, 2026 Sep 1, 2026
8-K Current report
Other events
Aug 24, 2026 Aug 20, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.